Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Klippel-Feil syndrome in a boy exposed inadvertently to cyclophosphamide during pregnancy: a case report.

Lazalde B, Grijalva-Flores J, Guerrero-Romero F.

Birth Defects Res A Clin Mol Teratol. 2012 Apr;94(4):249-52. doi: 10.1002/bdra.23004. Epub 2012 Mar 27.

PMID:
22450872
2.

Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?

Enns GM, Roeder E, Chan RT, Ali-Khan Catts Z, Cox VA, Golabi M.

Am J Med Genet. 1999 Sep 17;86(3):237-41. Review.

PMID:
10482872
3.

Cyclophosphamide for lupus during pregnancy.

Clowse ME, Magder L, Petri M.

Lupus. 2005;14(8):593-7.

PMID:
16175930
4.

Teratogenic effects of first-trimester cyclophosphamide therapy.

Kirshon B, Wasserstrum N, Willis R, Herman GE, McCabe ER.

Obstet Gynecol. 1988 Sep;72(3 Pt 2):462-4.

PMID:
3136412
5.

Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide.

Rengasamy P.

Anticancer Agents Med Chem. 2017;17(9):1211-1227. doi: 10.2174/1871520616666161206150421. Review.

PMID:
27924730
6.

Systemic lupus erythematosus.

Stratta P, Canavese C, Santi S, Ciccone G, Rosso S.

Lancet. 2001 Aug 18;358(9281):586-7. No abstract available.

PMID:
11526931
7.

Cyclophosphamide and the Teratology Society: an awkward marriage.

Ozolins TR.

Birth Defects Res B Dev Reprod Toxicol. 2010 Aug;89(4):289-99. doi: 10.1002/bdrb.20255. Review.

PMID:
20803689
8.

Hyperbaric oxygen therapy for cyclophosphamide-induced intractable refractory hemorrhagic cystitis in a systemic lupus erythematosus patient.

Jou YC, Lien FC, Cheng MC, Shen CH, Lin CT, Chen PC.

J Chin Med Assoc. 2008 Apr;71(4):218-20. doi: 10.1016/S1726-4901(08)70108-4.

9.

[Systemic lupus erythematosus and pregnancy. Presentation of 2 cases and review of the literature].

Livas Rodríguez S, Triana Saldaña HG, Ploneda González C.

Ginecol Obstet Mex. 1989 Jul;57:182-4. Review. Spanish.

PMID:
2486947
10.

A case of Klippel-Feil syndrome with congenital enlarged Eustachian tube.

Jovankovičová A, Jakubíková J, Durovčíková D.

Int J Pediatr Otorhinolaryngol. 2012 Apr;76(4):596-600. doi: 10.1016/j.ijporl.2012.01.007. Epub 2012 Jan 31.

PMID:
22301355
11.

[Severe hyponatraemia secondary to cure of cyclophosphamide (about three cases)].

Alilou M, Awab A, Zarouf M, Moussaoui RE, Hijri AE, Azzouzi A, Slaoui A.

Ann Fr Anesth Reanim. 2009 Jan;28(1):103-4. doi: 10.1016/j.annfar.2008.11.009. Epub 2009 Jan 6. French. No abstract available.

PMID:
19128924
12.

Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway?

Vaux KK, Kahole NC, Jones KL.

Birth Defects Res A Clin Mol Teratol. 2003 Jun;67(6):403-8.

PMID:
12962283
13.

Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.

Vasquez S, Kavanaugh AF, Schneider NR, Wacholtz MC, Lipsky PE.

J Rheumatol. 1992 Oct;19(10):1625-7.

PMID:
1464880
14.

[Total anomalous pulmonary venous connection associated with Klippel-Feil syndrome: a case report].

Masuda H, Arikawa K, Yuda T, Taira A.

Kyobu Geka. 1991 May;44(5):417-20. Review. Japanese.

PMID:
2051686
15.

Therapy-related myelodysplastic syndrome following cyclophosphamide pulse and/or methotrexate therapy in a patient with systemic lupus erythematosus.

Iwadate H, Kobayashi H, Yano K, Watanabe H, Ikeda K, Ogawa K, Ohira H.

Fukushima J Med Sci. 2010 Dec;56(2):121-7.

16.
17.

[Extracranial vertebral artery aneurysm complicating Klippel-Feil syndrome: case report].

Shimizu S, Kojima T, Morooka Y, Tanaka K, Nakagawa Y, Kuroki M.

No Shinkei Geka. 1996 Oct;24(10):933-7. Japanese.

PMID:
8914153
18.

Development of reticulum cell sarcoma during cyclophosphamide therapy.

Tannenbaum H, Schur PH.

Arthritis Rheum. 1974 Jan-Feb;17(1):15-8. No abstract available.

PMID:
4589814
19.

Agenesis of the right internal carotid artery and Klippel-Feil syndrome: case report.

Braga M, Pederzoli M, Beretta S, Ferrarini M, Canovaro P, Arpaia G, Crespi V.

Spine (Phila Pa 1976). 2009 Sep 15;34(20):E740-2. doi: 10.1097/BRS.0b013e3181b41181.

PMID:
19752694
20.

Supplemental Content

Support Center